Genex Pharmaceutical, Inc.
GENX · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $430 | $192 | $296 | $326 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $164 | $173 | $821 | $689 |
| Inventory | $485 | $460 | $455 | $523 |
| Other Curr. Assets | $1,062 | $709 | $2,672 | $1,171 |
| Total Curr. Assets | $2,140 | $1,534 | $4,245 | $2,708 |
| Property Plant & Equip (Net) | $196 | $131 | $177 | $231 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6,312 | $4,080 | $0 | $0 |
| Total NC Assets | $6,509 | $4,211 | $177 | $231 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $8,649 | $5,745 | $4,422 | $2,939 |
| Liabilities | – | – | – | – |
| Payables | $589 | $5 | $2 | $200 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $959 | $675 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,930 | $954 | $1,067 | $126 |
| Total Curr. Liab. | $3,478 | $1,634 | $1,068 | $326 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $431 | $45 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $37 | $0 |
| Total NC Liab. | $431 | $45 | $37 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,909 | $1,678 | $1,105 | $326 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | $2,528 | $2,276 | $1,776 | $1,245 |
| AOCI | $540 | $210 | $391 | $220 |
| Other Equity | $1,670 | $1,580 | $1,147 | $1,147 |
| Total Equity | $4,740 | $4,067 | $3,316 | $2,613 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $8,649 | $5,745 | $4,422 | $2,939 |
| Net Debt | -$430 | -$192 | -$296 | -$326 |